Latest News

Date Title Topic
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
Curriculum in Translational Research in Breast Cancer
25 Apr 2014 Recommendations for a Molecular Diagnostics Curriculum Personalised medicine - Bioethics, legal and economic issues - Translational research
25 Apr 2014 ESMO is Hiring
24 Apr 2014 Biomarker Enrichment Strategies Personalised medicine - Translational research
23 Apr 2014 FDA Approves Ramucirumab for Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Gastrointestinal cancers
22 Apr 2014 New Options for Treatment of Metastatic Sarcoma Pose a Challenge in Selecting the Best One Sarcomas
22 Apr 2014 European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Anti-Cancer Medicines Identified Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
18 Apr 2014 Does a More Refined Categorisation of Tumour Response and/or Progression Improve Prediction of Overall Survival in RECIST 1.1? Anticancer agents & Biologic therapy
17 Apr 2014 European Medicines Agency and EU National Competent Authorities Agree on Action Plan to Address Medication Errors Bioethics, legal and economic issues
16 Apr 2014 In-depth Focus on Effective Cancer Control and Care in China, India, and Russia Epidemiology/Etiology/Cancer Prevention
15 Apr 2014 A Meta-Analysis of First Generation EGFR TKIs vs. Chemotherapy in Patients with Wild Type EGFR Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2014 A Subset of Breast Cancer Patients Most Likely to Benefit From Neoadjuvant Regimen With Pan-HER Inhibitor Neratinib Breast cancer - Anticancer agents & Biologic therapy